Citron Sees the Valuation, but Misses the Technology

Damnang · Damnang’s Substack · April 11, 2026 at 04:34 · ⏱ 18 min read  | Read on Substack ↗
Summary
The article argues that Citron Research's short thesis on Applied Optoelectronics (AAOI) is flawed because it ignores AAOI's vertical integration in laser and epitaxy manufacturing, which becomes more valuable as the optical industry shifts to LPO and CPO architectures. This means AAOI is not a commodity hardware company, contrary to Citron's claim, and the market should reconsider the bear case based on technology fundamentals rather than just valuation metrics.
  • AAOI designs and fabricates its own lasers and optical subassemblies in-house, including DFB and EML types on InP, and operates both MBE and MOCVD epitaxy systems.
  • LPO removes the DSP from optical transceivers, raising quality requirements across the analog link; AAOI's vertical integration allows co-optimization of the light source with the analog chain.
  • CPO does not diminish the value of lasers; InP-based external light sources remain critical, and AAOI demonstrated a 25 dBm ELSFP and 6.4T OBO at OFC 2026.
  • AAOI reported $456 million in 2025 revenue and expects over $1 billion in 2026, targeting 800G and 1.6T transceivers for AI data centers.
  • Customer concentration risk is real: Microsoft was 28.8% of 2025 revenue, and Oracle's debt ($130.9B) vs. RPO ($552.6B) creates uncertainty.
  • Citron's 'one Innolight price cut and it's over' argument ignores qualification switching costs, internal laser cost structure, and customer segmentation differences.
  • AAOI has a warrant structure with Amazon tied to cumulative discretionary purchases of $4 billion, but this is not a confirmed backlog.
Read time 18 min
Length 18,036 chars
Category finance
Trade Ideas
Damnang Substack author, Damnang’s Substack
The article provides a detailed technical rebuttal to Citron's bear thesis, arguing that AAOI's in-house laser/epitaxy capability and alignment with LPO/CPO trends make it a structurally differentiate
The article provides a detailed technical rebuttal to Citron's bear thesis, arguing that AAOI's in-house laser/epitaxy capability and alignment with LPO/CPO trends make it a structurally differentiated player, not a commodity hardware company. This positive framing, while not a buy recommendation, suggests potential upside if the market re-evaluates the technology thesis. Risk: Execution risk, customer concentration (Microsoft, Oracle), high valuation, and potential price competition from larger players like Innolight remain key downside factors.

This newsletter, published April 11, 2026, features Damnang discussing AAOI. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: Damnang  · Tickers: AAOI